- Investing Ideas
- Japanese Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Japanese Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Results
14
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
14 companies
Chugai Pharmaceutical
Market Cap: JP¥14.3t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥8,675.00
7D
-1.2%
1Y
38.0%
Otsuka Holdings
Market Cap: JP¥5.6t
Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.
4578
JP¥10,650.00
7D
-5.1%
1Y
58.4%
Daiichi Sankyo Company
Market Cap: JP¥5.1t
Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.
4568
JP¥2,772.50
7D
-3.2%
1Y
-10.7%
Astellas Pharma
Market Cap: JP¥4.7t
Manufactures, markets, imports, and exports pharmaceuticals in Japan and internationally.
4503
JP¥2,607.00
7D
0.8%
1Y
105.4%
Shionogi
Market Cap: JP¥2.9t
Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.
4507
JP¥3,371.00
7D
-5.4%
1Y
56.2%
Eisai
Market Cap: JP¥1.4t
Engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in India.
4523
JP¥5,025.00
7D
-0.04%
1Y
41.5%
Kyowa Kirin
Market Cap: JP¥1.3t
Engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally.
4151
JP¥2,566.00
7D
-1.3%
1Y
23.1%
Ono Pharmaceutical
Market Cap: JP¥1.2t
Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.
4528
JP¥2,509.50
7D
-0.9%
1Y
54.2%
Santen Pharmaceutical
Market Cap: JP¥587.5b
Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.
4536
JP¥1,826.50
7D
0.05%
1Y
39.0%
Hisamitsu Pharmaceutical
Market Cap: JP¥423.8b
Manufactures and sells pharmaceuticals in Japan.
4530
JP¥6,045.00
7D
0.1%
1Y
41.0%
Sawai Group Holdings
Market Cap: JP¥260.5b
Together with subsidiaries, engages in the research and development, manufacture, and marketing of generic pharmaceuticals.
4887
JP¥2,255.50
7D
-2.0%
1Y
21.1%
Kissei Pharmaceutical
Market Cap: JP¥194.8b
Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.
4547
JP¥4,700.00
7D
-2.6%
1Y
32.8%
KYORIN Pharmaceutical
Market Cap: JP¥95.2b
Through its subsidiaries, researches and develops, manufactures, and sells ethical and generic drugs in Japan and internationally.
4569
JP¥1,657.00
7D
-2.2%
1Y
16.9%
Daito PharmaceuticalLtd
Market Cap: JP¥40.9b
Engages in the manufacture and sale of pharmaceutical products in Japan and internationally.
4577
JP¥1,402.00
7D
-2.2%
1Y
31.6%